Dreman Value Management’s Integra LifeSciences IART Stock Holding History

Dreman Value Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-44,516	Closed	-$1.5M	–	494
2016 Q1	$1.5M	Buy	+44,516	New	+$1.39M	0.17%	142
2015 Q4	–	Sell	-165,938	Closed	-$4.94M	–	289
2015 Q3	$4.94M	Sell	165,938 -195,570	-54%	-$6.12M	0.5%	72
2015 Q2	$9.96M	Buy	361,508 +29,551	+9%	+$788K	0.82%	32
2015 Q1	$8.37M	Buy	331,957 +26,285	+9%	+$621K	0.72%	48
2014 Q4	$6.78M	Buy	305,672 +18,319	+6%	+$371K	0.56%	59
2014 Q3	$5.83M	Buy	287,353 +3,682	+1%	+$73.3K	0.47%	99
2014 Q2	$5.46M	Sell	283,671 -6,236	-2%	-$116K	0.41%	128
2014 Q1	$5.45M	Buy	289,907 +8,805	+3%	+$170K	0.42%	117
2013 Q4	$5.5M	Buy	281,102 +35,320	+14%	+$648K	0.42%	117
2013 Q3	$4.04M	Buy	+245,782	New	+$3.94M	0.36%	120

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dreman Value Management's IART Position: Q2 2016 in Review

Dreman Value Management sold out of Integra LifeSciences (IART) in Q2 2016, closing a stake of 44,516 shares — an estimated $1.5M sold.

Dreman Value Management first reported a position in IART in Q3 2013 and held it in 10 quarters. The position peaked at $9.96M in Q2 2015. 210 funds tracked by Wall St. Rank hold IART as of Q2 2016.

Dreman Value Management reported no remaining Integra LifeSciences position as of Q2 2016 after selling out during the quarter.
Dreman Value Management sold 44,516 Integra LifeSciences shares in Q2 2016, an estimated $1.5M.
Dreman Value Management first reported a position in Integra LifeSciences in Q3 2013 and held it in 10 quarters.
Dreman Value Management's Integra LifeSciences position peaked at $9.96M in Q2 2015.
210 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on Dreman Value Management's 13F filing for Q2 2016, filed 15 Aug 2016.